Last reviewed · How we verify

NCT04777305: POWER

The POWER BARIATRIC Trial: Physical Outcomes With Exercise Regimens on BARIATRIC Patients

Status unknown NA Last updated 27 October 2023
What this trial tests

NA trial testing Physical activity training in Obesity in 60 participants. Status unknown.

Timeline
1 August 2021
Primary endpoint
30 October 2024
30 October 2024

Quick facts

Lead sponsorTel Aviv University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeprevention
Enrollment60
Start date1 August 2021
Primary completion30 October 2024
Estimated completion30 October 2024
Sites1 location across Israel

Drugs / interventions tested

Conditions studied

Sponsor

Tel Aviv University

Who can join

Adults 20 to 65, any sex, with Obesity or Muscle Loss. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to determine how different types of exercise regimens (resistance, aerobic, or combined exercise regimens) can be used to minimize muscle loss and mobilize body fat in severely obese patients after bariatric surgery (BS), despite the rapid surgery-induced weight loss. Additionally, the study will examine how changes in the intestinal microbiota following BS act as a mediation factor that alter tissue-specific responses in muscle and adipose tissue. The study will also evaluate the effect of different types of exercise regimens on cardiometabolic markers, endocrine response, and physical function following BS. Sixty sedentary (regular exercise \<1 hour per week) candidates to bariatric surgery at Herzliya Medical Center will be recruited to participate in this six-month-long randomized control study. Participants will be randomly assigned to either one of three exercise regimens intervention groups (aerobic, resistance, or a combined exercise regimen combining aerobic and resistance exercises) or a control group that will receive standard care. Training will be supervised and matched for metabolic equivalent (METs). The intervention will take place at the Sylvan Adams Sports Institute at Tel Aviv University and an online platform. All measurements will be taken at a presurgical baseline assessment and throughout the study, and will include changes of muscle mass and adipose tissue distribution, measured by a 3-Tesla magnetic resonance imaging (MRI); body composition- will be assessed using multichannel bioelectrical impedance (Seca); Bone mass, will be measured by a Dual-energy X-ray absorptiometry (DEXA); microbiota composition and changes will be evaluated by stool samples that will be subjected to 16S ribosomal ribonucleic acid (16s rRNA) profiling and metagenomics analysis; fasting blood samples will be used to examine endocrine control and cardiometabolic markers; anthropometric measurements to assess surgery results associations with physical activity outcomes and physical function will be assessed by several validated performance assessments, including handgrip, six-minute walk, sit-to-stand, maximum voluntary contraction, and maximal oxygen consumption (VO2max).

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Exercise Modalities to Preserve Muscle Mass and Bone Health After Metabolic Bariatric Surgery.
    Goldenshluger A, Friedman L, Turjeman T, Yavetz R, et al · · 2026 · PMID 42057763 · DOI 10.1002/jcsm.70289
  2. Liver and Kidney volume Reduction May Underlie Metabolic Adaptation After Metabolic Bariatric Surgery: A sub-study of the "POWER" Randomized clinical trial.
    Friedman L, Goldenshluger A, Turjeman T, Raziel A, et al · · 2026 · PMID 41875670 · DOI 10.1016/j.clnu.2026.106623

Verify or expand the search:

Other trials of Physical activity training

Trials testing the same drug.

Other recruiting trials for Obesity

Currently open trials in the same condition.

Other Tel Aviv University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04777305.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing